Literature DB >> 18776126

Toll-like receptor 9 affects severity of IgA nephropathy.

Hitoshi Suzuki1, Yusuke Suzuki, Ichiei Narita, Masashi Aizawa, Masao Kihara, Takahiro Yamanaka, Tatsuya Kanou, Hiroyasu Tsukaguchi, Jan Novak, Satoshi Horikoshi, Yasuhiko Tomino.   

Abstract

Environmental pathogens are suspected to aggravate renal injury in IgA nephropathy (IgAN), but neither underlying mechanisms nor specific exogenous antigens have been identified. In this study, a genome-wide scan of ddY mice, which spontaneously develop IgAN, was performed, and myeloid differentiation factor 88 (MyD88) was identified as a candidate gene for progression of renal injury (chi(2) = 21.103, P = 0.00017). For evaluation of the potential influence of environmental pathogens on progression of renal injury, ddY mice were housed in either conventional or specific pathogen-free conditions. Expression of genes encoding toll-like receptors (TLR) and the signaling molecule MyD88 were quantified by real-time reverse transcription-PCR in splenocytes. Although the housing conditions did not affect the prevalence of IgAN, the severity of renal injuries was higher in the conventionally housed group. Mice that had IgAN and were housed in conventional conditions had higher levels of TLR9 and MyD88 transcripts than mice that had IgAN and were housed in specific pathogen-free conditions. Furthermore, nasal challenge with CpG-oligodeoxynucleotides, which are ligands for TLR9, aggravated renal injury, led to strong Th1 polarization, and increased serum and mesangial IgA. For investigation of whether these results may be generalizable to humans, single-nucleotide polymorphisms in the TLR9 and MyD88 genes were analyzed in two cohorts of patients with IgAN; an association was observed between TLR9 polymorphisms and disease progression. In summary, these findings suggest that activation of the TLR9/MyD88 pathway by common antigens may affect the severity of IgAN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776126      PMCID: PMC2588104          DOI: 10.1681/ASN.2007121311

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

1.  Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy.

Authors:  J Song; I Narita; S Goto; N Saito; K Omori; F Sato; J Ajiro; D Saga; D Kondo; M Sakatsume; F Gejyo
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

2.  Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy.

Authors:  Fumihiro Akiyama; Toshihiro Tanaka; Ryo Yamada; Yozo Ohnishi; Tatsuhiko Tsunoda; Shiro Maeda; Takashi Takei; Wataru Obara; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta; Wako Yumura; Hiroshi Nihei; Takashi Ujiie; Yutaka Nagane; Satoru Miyano; Yasushi Suzuki; Tomoaki Fujioka; Ichiei Narita; Fumitake Gejyo; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

3.  A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy.

Authors:  Shin Goto; Ichiei Narita; Noriko Saito; Yasuo Watanabe; Hajime Yamazaki; Minoru Sakatsume; Hisaki Shimada; Shinichi Nishi; Mitsuhiro Ueno; Kohei Akazawa; Masaaki Arakawa; Fumitake Gejyo
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

4.  Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.

Authors:  Hans-Joachim Anders; Bernhard Banas; Yvonne Linde; Lars Weller; Clemens D Cohen; Matthias Kretzler; Stefan Martin; Volker Vielhauer; Detlef Schlöndorff; Hermann-Josef Gröne
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

5.  Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies.

Authors:  Ross Lazarus; Walter T Klimecki; Benjamin A Raby; Donata Vercelli; Lyle J Palmer; David J Kwiatkowski; Edwin K Silverman; Fernando Martinez; Scott T Weiss
Journal:  Genomics       Date:  2003-01       Impact factor: 5.736

6.  Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Vaclav Eis; Yvonne Linde; Matthias Kretzler; Guillermo Perez de Lema; Frank Strutz; Stefan Bauer; Mark Rutz; Hermann Wagner; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

7.  Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.

Authors:  Ichiei Narita; Shin Goto; Noriko Saito; Jin Song; Junya Ajiro; Fuminori Sato; Daisuke Saga; Daisuke Kondo; Kohei Akazawa; Minoru Sakatsume; Fumitake Gejyo
Journal:  Hypertension       Date:  2003-07-28       Impact factor: 10.190

Review 8.  Inherited forms of IgA nephropathy.

Authors:  Francesco Scolari
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version.

Authors:  Yasuhiko Tomino; Hideto Sakai
Journal:  Clin Exp Nephrol       Date:  2003-06       Impact factor: 2.801

View more
  71 in total

1.  Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

Authors:  M Shimizu; N P Nikolov; K Ueno; K Ohta; R M Siegel; A Yachie; F Candotti
Journal:  Clin Immunol       Date:  2011-10-19       Impact factor: 3.969

2.  Development of Animal Models of Human IgA Nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Jan Novak; Yasuhiko Tomino
Journal:  Drug Discov Today Dis Models       Date:  2014

Review 3.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

4.  A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy.

Authors:  Jin-Soon Suh; Seong H Cho; Joo-Ho Chung; Ahrim Moon; Yong-Koo Park; Byoung-Soo Cho
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

Review 5.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

Review 6.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

7.  Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.

Authors:  Masahiro Muto; Benoit Manfroi; Hitoshi Suzuki; Kensuke Joh; Masaaki Nagai; Sachiko Wakai; Christian Righini; Masayuki Maiguma; Shozo Izui; Yasuhiko Tomino; Bertrand Huard; Yusuke Suzuki
Journal:  J Am Soc Nephrol       Date:  2016-12-05       Impact factor: 10.121

Review 8.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

9.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

10.  Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.

Authors:  Akihiro Hoshino; Masaki Shimizu; Hiroyoshi Matsukura; Hisano Sakaki-Nakatsubo; Keiko Nomura; Toshio Miyawaki; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2013-11-12       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.